Evidence map›Paper›PMID 36141692›Full record

ArticleInternational journal of environmental research and public health2022

The Level of COVID-19 Anxiety among Oncology Patients in Poland.

Mateusz Grajek, Karolina Krupa-Kotara, Mateusz Rozmiarek, Karolina Sobczyk, Eliza Działach, Michał Górski, Joanna Kobza

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. The Social-Psychological Consequences of COVID-19: An Integrative Review and Research Agenda.International journal of environmental research and public health · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mateusz GrajekDepartment of Public Health, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.ORCID 0000-0001-6588-8598
Karolina Krupa-KotaraDepartment of Epidemiology, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.ORCID 0000-0001-9330-0771
Mateusz RozmiarekDepartment of Sports Tourism, Faculty of Physical Culture Sciences, Poznan University of Physical Education, 61871 Poznan, Poland.ORCID 0000-0002-5955-0790
Karolina SobczykDepartment of Health Economics and Health Management, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.
Eliza DziałachDepartment of Public Health, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.
Michał GórskiDepartment of Dietetics, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.
Joanna KobzaDepartment of Public Health, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 40055 Katowice, Poland.
Medical University of Silesia · PLUniversity School of Physical Education in Kraków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients tend to have a high psychological burden. Half of cancer patients suffer from severe affective disorders and anxiety disorders, while one-third struggle with mild forms of these. The COVID-19 pandemic is damaging the mental health of the population due to social restrictions. A growing number of studies note the role of COVID-19 anxiety in the health and quality of life of cancer patients. The purpose of this study is to estimate the level of COVID-19 anxiety among oncology patients and to test the utility of the FCV-19S scale in a population study of cancer patients. The study included 600 respondents (300 oncology patients and 300 control subjects not undergoing oncological treatment). The FCV-19S scale and the GAD-7 scale were used in the study. The results were interpreted according to the following verbal scale: 76-100%, high anxiety; 56-75%, moderate anxiety; 26-55%, low COVID-19 anxiety; <25%, no COVID-19 anxiety. In the analysis of the GAD-7 questionnaire results, the mean score obtained was 8.21 (min. 0; max. 21; SD 5.32). For 81% of respondents in the group of oncology patients, the total score indicated the presence of anxiety symptoms with varying degrees of severity; in the control group, this proportion was 55% of respondents. The FCV-19S scale score as a percentage was 57.4% for oncology patients, indicating a moderate level of fear of the SARS-CoV-2 virus, and 30.3% for the control group, indicating a low level of fear of the SARS-CoV-2 virus. One-fifth of oncology patients were afraid of losing their lives due to the SARS-CoV-2 virus; in the control group, this proportion was 13% of respondents. Oncology patients were characterized by a higher prevalence of sleep disturbance than control group respondents, which was associated with greater anxiety. The study, therefore, shows that oncology patients have moderate levels of anxiety associated with the COVID-19 pandemic, and non-oncology patients show lower levels of anxiety.

Indexed as

COVID-19NeoplasmsAnxietyAnxiety DisordersHumansPandemicsPolandQuality of LifeSARS-CoV-2anxietyCOVID-19FCV-19SGAD-7oncologyPolandSARS-CoV-2

Identifiers

PMID36141692
PMCPMC9517625
OpenAlexW4296806748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.